VIEMED HEALTHCARE INC (VMD) Stock Fundamental Analysis
USA - NASDAQ:VMD - CA92663R1055 - Common Stock
6.82 USD
-0.05 (-0.73%)
6.9999 USD
+0.18 (+2.64%)
VMD gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. VMD scores excellent on profitability, but there are some minor concerns on its financial health. VMD is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, VMD could be worth investigating further for growth investing!.
1. Profitability
1.1 Basic Checks
VMD had positive earnings in the past year.
VMD had a positive operating cash flow in the past year.
Each year in the past 5 years VMD has been profitable.
VMD had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
VMD has a Return On Assets of 7.57%. This is amongst the best in the industry. VMD outperforms 89.11% of its industry peers.
With a decent Return On Equity value of 10.00%, VMD is doing good in the industry, outperforming 72.28% of the companies in the same industry.
VMD has a better Return On Invested Capital (7.91%) than 73.27% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for VMD is in line with the industry average of 9.20%.
The last Return On Invested Capital (7.91%) for VMD is above the 3 year average (7.66%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROIC | 7.91% |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
1.3 Margins
The Profit Margin of VMD (5.80%) is better than 81.19% of its industry peers.
In the last couple of years the Profit Margin of VMD has declined.
VMD has a Operating Margin of 6.82%. This is in the better half of the industry: VMD outperforms 67.33% of its industry peers.
VMD's Operating Margin has declined in the last couple of years.
VMD has a Gross Margin of 58.33%. This is amongst the best in the industry. VMD outperforms 80.20% of its industry peers.
In the last couple of years the Gross Margin of VMD has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% |
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so VMD is destroying value.
Compared to 1 year ago, VMD has more shares outstanding
The number of shares outstanding for VMD has been increased compared to 5 years ago.
The debt/assets ratio for VMD has been reduced compared to a year ago.
2.2 Solvency
VMD has an Altman-Z score of 5.99. This indicates that VMD is financially healthy and has little risk of bankruptcy at the moment.
VMD has a better Altman-Z score (5.99) than 86.14% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that VMD is not too dependend on debt financing.
VMD has a better Debt to Equity ratio (0.02) than 82.18% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 5.99 |
ROIC/WACC0.87
WACC9.09%
2.3 Liquidity
A Current Ratio of 1.48 indicates that VMD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.48, VMD is in line with its industry, outperforming 48.51% of the companies in the same industry.
VMD has a Quick Ratio of 1.37. This is a normal value and indicates that VMD is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.37, VMD is in line with its industry, outperforming 49.51% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 |
3. Growth
3.1 Past
VMD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.67%, which is quite impressive.
VMD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 4.01% yearly.
The Revenue has grown by 17.11% in the past year. This is quite good.
The Revenue has been growing by 22.80% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
3.2 Future
The Earnings Per Share is expected to grow by 24.89% on average over the next years. This is a very strong growth
VMD is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.73% yearly.
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 20.06, which indicates a rather expensive current valuation of VMD.
Compared to the rest of the industry, the Price/Earnings ratio of VMD indicates a somewhat cheap valuation: VMD is cheaper than 68.32% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.02, VMD is valued a bit cheaper.
The Price/Forward Earnings ratio is 13.92, which indicates a correct valuation of VMD.
Based on the Price/Forward Earnings ratio, VMD is valued a bit cheaper than 79.21% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of VMD to the average of the S&P500 Index (22.57), we can say VMD is valued slightly cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.06 | ||
| Fwd PE | 13.92 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, VMD is valued cheaply inside the industry as 90.10% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 5.87 |
4.3 Compensation for Growth
VMD's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of VMD may justify a higher PE ratio.
A more expensive valuation may be justified as VMD's earnings are expected to grow with 24.89% in the coming years.
PEG (NY)0.65
PEG (5Y)5
EPS Next 2Y32.27%
EPS Next 3Y24.89%
5. Dividend
5.1 Amount
VMD does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
6.82
-0.05 (-0.73%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners68.04%
Inst Owner ChangeN/A
Ins Owners13.25%
Ins Owner Change1%
Market Cap264.55M
Analysts80
Price Target13.94 (104.4%)
Short Float %1.37%
Short Ratio1.75
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.99%
Min EPS beat(2)-0.99%
Max EPS beat(2)-0.99%
EPS beat(4)1
Avg EPS beat(4)6.08%
Min EPS beat(4)-5.7%
Max EPS beat(4)32.01%
EPS beat(8)1
Avg EPS beat(8)-11.48%
EPS beat(12)3
Avg EPS beat(12)-7.67%
EPS beat(16)4
Avg EPS beat(16)-7.02%
Revenue beat(2)0
Avg Revenue beat(2)-2.23%
Min Revenue beat(2)-3.39%
Max Revenue beat(2)-1.06%
Revenue beat(4)2
Avg Revenue beat(4)-0.93%
Min Revenue beat(4)-3.39%
Max Revenue beat(4)0.49%
Revenue beat(8)5
Avg Revenue beat(8)-0.39%
Revenue beat(12)8
Avg Revenue beat(12)0.05%
Revenue beat(16)12
Avg Revenue beat(16)0.96%
PT rev (1m)0%
PT rev (3m)5.13%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.8%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.59%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.06 | ||
| Fwd PE | 13.92 | ||
| P/S | 1.1 | ||
| P/FCF | N/A | ||
| P/OCF | 6.18 | ||
| P/B | 1.89 | ||
| P/tB | 2.5 | ||
| EV/EBITDA | 5.87 |
EPS(TTM)0.34
EY4.99%
EPS(NY)0.49
Fwd EY7.18%
FCF(TTM)-0.09
FCFYN/A
OCF(TTM)1.1
OCFY16.19%
SpS6.21
BVpS3.6
TBVpS2.73
PEG (NY)0.65
PEG (5Y)5
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.57% | ||
| ROE | 10% | ||
| ROCE | 11.16% | ||
| ROIC | 7.91% | ||
| ROICexc | 9.15% | ||
| ROICexgc | 12.45% | ||
| OM | 6.82% | ||
| PM (TTM) | 5.8% | ||
| GM | 58.33% | ||
| FCFM | N/A |
ROA(3y)6.09%
ROA(5y)10.79%
ROE(3y)7.98%
ROE(5y)14.42%
ROIC(3y)7.66%
ROIC(5y)10.17%
ROICexc(3y)8.81%
ROICexc(5y)13.58%
ROICexgc(3y)11.22%
ROICexgc(5y)15.03%
ROCE(3y)10.8%
ROCE(5y)14.35%
ROICexcg growth 3Y2.65%
ROICexcg growth 5Y-2.94%
ROICexc growth 3Y-7.87%
ROICexc growth 5Y-9.04%
OM growth 3Y-11.38%
OM growth 5Y-8.84%
PM growth 3Y-13.54%
PM growth 5Y-13.85%
GM growth 3Y-1.78%
GM growth 5Y-3.16%
F-Score8
Asset Turnover1.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.02 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.08 | ||
| Cap/Depr | 176.74% | ||
| Cap/Sales | 19.28% | ||
| Interest Coverage | 25.41 | ||
| Cash Conversion | 100.29% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.48 | ||
| Quick Ratio | 1.37 | ||
| Altman-Z | 5.99 |
F-Score8
WACC9.09%
ROIC/WACC0.87
Cap/Depr(3y)138.25%
Cap/Depr(5y)145.08%
Cap/Sales(3y)15.87%
Cap/Sales(5y)14.88%
Profit Quality(3y)92.19%
Profit Quality(5y)75.37%
High Growth Momentum
Growth
EPS 1Y (TTM)41.67%
EPS 3Y8.37%
EPS 5Y4.01%
EPS Q2Q%100%
EPS Next Y31.06%
EPS Next 2Y32.27%
EPS Next 3Y24.89%
EPS Next 5YN/A
Revenue 1Y (TTM)17.11%
Revenue growth 3Y24.18%
Revenue growth 5Y22.8%
Sales Q2Q%14.72%
Revenue Next Year18.33%
Revenue Next 2Y17.92%
Revenue Next 3Y17.73%
Revenue Next 5YN/A
EBIT growth 1Y5.79%
EBIT growth 3Y10.05%
EBIT growth 5Y11.94%
EBIT Next Year219.91%
EBIT Next 3Y63.61%
EBIT Next 5YN/A
FCF growth 1Y-132.43%
FCF growth 3Y-21.74%
FCF growth 5Y-25.39%
OCF growth 1Y26.82%
OCF growth 3Y20.23%
OCF growth 5Y15.41%